Eli Lilly (LLY) FCF Payout Ratio (2009 - 2026)

Eli Lilly has reported FCF Payout Ratio for 18 years, with the latest figure at 0.51 in Q1 2026.

• For the quarter ending Q1 2026, FCF Payout Ratio fell 94.03% year-over-year to 0.51; the trailing twelve-month figure through Mar 2026 stood at 0.47 (down 63.65% YoY), and the FY2025 full-year result was 0.6, down 51.79% from the prior year.
• FCF Payout Ratio for Q1 2026 stood at 0.51, down from 1.98 in the prior quarter.
• The five-year high for FCF Payout Ratio was 8.63 in Q1 2025, with the low at 19.13 in Q2 2023.
• Historically, FCF Payout Ratio has averaged 0.66 across 5 years, with a median of 0.83 in 2023.
• Annual changes were most pronounced in 2023 — FCF Payout Ratio sank 980.17% — and 2024, when it jumped 579.36%.
• Eli Lilly's FCF Payout Ratio stood at 0.76 in 2022, then tumbled by 196.69% to 0.74 in 2023, then jumped by 262.32% to 1.19 in 2024, then jumped by 66.16% to 1.98 in 2025, then slumped by 74.06% to 0.51 in 2026.
• The last three FCF Payout Ratio figures came in at 0.51 (Q1 2026), 1.98 (Q4 2025), and 0.2 (Q3 2025), per Business Quant data.